Edwards Lifesciences (EW) Misses Q2 EPS by 1c, Q3 Revenue Guidance Misses
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $85.88 -1.69%
EPS Growth %: +10.4%
Financial Fact:
Diluted (in dollars per share): 0.65
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +10.4%
Financial Fact:
Diluted (in dollars per share): 0.65
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.4 billion.
GUIDANCE:
Edwards Lifesciences sees Q3 2022 EPS of $0.58-$0.66, versus the consensus of $0.65. Edwards Lifesciences sees Q3 2022 revenue of $1.3-1.37 billion, versus the consensus of $1.44 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
